Abstract
摘要
相似文献
1
No alert from CPMP on oral contraceptives.
Lancet. 1996 Apr 27;347(9009):1175.
2
Scare over oral contraceptives. Studies implicate only gestodene and desogestrel.
BMJ. 1995 Dec 16;311(7020):1639. doi: 10.1136/bmj.311.7020.1639b.
3
Epidemiology of oral contraceptives and cardiovascular disease.
Ann Intern Med. 1998 Nov 1;129(9):747. doi: 10.7326/0003-4819-129-9-199811010-00018.
4
Pregnancies and terminations after 1995 warning about third-generation oral contraceptives.
Lancet. 1998 May 9;351(9113):1404-5. doi: 10.1016/S0140-6736(05)79443-5.
5
Third generation oral contraceptives--the controversy.
BMJ. 1995 Dec 16;311(7020):1589-90. doi: 10.1136/bmj.311.7020.1589.
6
[Third-generation oral contraceptives--how big is the risk of venous thrombosis?].
Tidsskr Nor Laegeforen. 2004 Jun 3;124(11):1521-2.
7
Third generation oral contraceptives.
BMJ. 2000 Jul 22;321(7255):190-1. doi: 10.1136/bmj.321.7255.190.
8
Oral contraceptives and venous thromboembolism.
Int J Gynaecol Obstet. 1996 Jul;54(1):45-50. doi: 10.1016/0020-7292(96)02669-0.
9
Risk of idiopathic cerebral haemorrhage in women on oral contraceptives with differing progestagen components.
Lancet. 1999 Jul 24;354(9175):302-3. doi: 10.1016/S0140-6736(99)01014-4.
Zotero 插件